NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-170-2013-1-AU-02 CHIMERIC ANTIGEN RECEPTORS TO CONTROL HIV INFECTION AU National Stage 2014352638 Issued
NIAID E-170-2013-1-EP-04 CHIMERIC ANTIGEN RECEPTORS TO CONTROL HIV INFECTION EP National Stage 14812376.3 Issued
NICHD E-552-2013-0-EP-08 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE EP National Stage 14812375.5 Issued
NICHD E-552-2013-0-NL-22 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE NL EP 14812375.5 Issued
NICHD E-552-2013-0-IT-21 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE IT EP 14812375.5 Issued
NICHD E-552-2013-0-ES-18 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE ES EP 14812375.5 Issued
NICHD E-552-2013-0-SE-23 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE SE EP 14812375.5 Issued
NICHD E-552-2013-0-BE-15 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE BE EP 14812375.5 Issued
NICHD E-552-2013-0-FR-19 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE FR EP 14812375.5 Issued
NICHD E-552-2013-0-DE-17 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE DE EP 14812375.5 Issued
NICHD E-552-2013-0-GB-20 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE GB EP 14812375.5 Issued
NICHD E-552-2013-0-CH-16 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE CH EP 14812375.5 Issued
NCI E-321-2003-0-AU-11 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 AU DIV 2014268156 Issued
NCI E-136-2012-0-US-07 High-Affinity Monoclonal Antibodies To Glypican-3 And Use Thereof US National Stage 14/403,896 9409994 Issued PDF
NICHD E-552-2013-0-PCT-02 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE PCT PCT PCT/US2014/067415 Expired
NIAID E-170-2013-1-PCT-01 CHIMERIC ANTIGEN RECEPTORS TO CONTROL HIV INFECTION PCT PCT COMB PCT/US2014/067459 Expired
NINDS E-017-2015-0-US-01 Compounds Targeting Hypoxia-inducible Factor 2 Alpha US 62/084,455 Abandoned
NIDDK E-194-2012-0-US-03 Eukaryotic Transposase Mutants And Transposon End Compositions For Modifying Nucleic Acids And Methods For Production And Use In The Generation Of Sequencing Libraries US National Stage 14/403,506 Abandoned
NIA E-139-2012-2-US-06 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES US National Stage 14/403,516 Abandoned
NICHD E-008-2015-0-US-01 Joint Probability Distrbution Determinations for Material Assessments US 62/083,834 Abandoned
NHLBI E-124-2014-1-US-01 Devices and Methods For Closure Of Transvascular Or Transcameral Access Ports US 62/083,192 Abandoned
NIA E-139-2012-2-JP-05 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES JP National Stage 2015-514191 Issued
NHLBI E-122-2006-0-US-04 COMPOSITIONS AND METHODS FOR PREVENTION OR TREATMENT OF NEOPLASTIC DISEASE IN A MAMMALIAN SUBJECT US CON 14/549,296 9856453 Issued PDF
NIDDK E-011-2014-0-PCT-02 Heterocyclic Compounds and Methods of Use Thereof PCT PCT PCT/US2014/066680 Expired
NIDDK E-742-2013-0-PCT-02 A3 Adenosine Receptor Agonists PCT PCT PCT/US2014/066609 Expired
NIDDK E-011-2014-0-EP-07 Piperidine and Piperazine Derivatives and Their Use in Treating Viral Infections and Cancer EP National Stage 14809235.6 Abandoned
NIDDK E-011-2014-0-AU-04 Piperidine and Piperazine Derivatives and Their Use in Treating Viral Infections and Cancer AU National Stage 2014354957 Abandoned
NIDDK E-011-2014-0-KR-10 Piperidine and Piperazine Derivatives and Their Use in Treating Viral Infections and Cancer KR National Stage 10-2016-7014314 Abandoned
NIDDK E-011-2014-0-CA-05 Piperidine and Piperazine Derivatives and Their Use in Treating Viral Infections and Cancer CA National Stage 2931804 Abandoned
NCI E-105-2012-0-IT-24 Murine Anti-NY-ESO-1 T Cell Receptors IT EP 13726389.3 Issued
NCI E-105-2012-0-IE-23 Murine Anti-NY-ESO-1 T Cell Receptors IE EP 13726389.3 Issued
NCI E-105-2012-0-ES-20 Murine Anti-NY-ESO-1 T Cell Receptors ES EP 13726389.3 Issued
NCI E-105-2012-0-PT-26 Murine Anti-NY-ESO-1 T Cell Receptors PT EP 13726389.3 Issued
NCI E-105-2012-0-NL-25 Murine Anti-NY-ESO-1 T Cell Receptors NL EP 13726389.3 Issued
NCI E-105-2012-0-CH-18 Murine Anti-NY-ESO-1 T Cell Receptors CH EP 13726389.3 Issued
NCI E-105-2012-0-GB-22 Murine Anti-NY-ESO-1 T Cell Receptors GB EP 13726389.3 Issued
NCI E-105-2012-0-AT-16 Murine Anti-NY-ESO-1 T Cell Receptors AT EP 13726389.3 Issued
NCI E-105-2012-0-BE-17 Murine Anti-NY-ESO-1 T Cell Receptors BE EP 13726389.3 Issued
NCI E-105-2012-0-FR-21 Murine Anti-NY-ESO-1 T Cell Receptors FR EP 13726389.3 Issued
NCI E-105-2012-0-DE-19 Murine Anti-NY-ESO-1 T Cell Receptors DE EP 13726389.3 Issued
NHLBI E-051-2019-0-CN-04 Methods and systems for automatically determining magnetic field inversion time of a tissue species CN ORD 201410154479.4 Pending
NCI E-105-2012-0-US-09 Murine Anti-NY-ESO-1 T Cell Receptors US National Stage 14/401,893 9487573 Issued PDF
NCI E-263-2011-0-HK-07 Pseudomonas Exotoxin A With Less Immunogenic B Cell Epitopes HK EP 14111650.2 Abandoned
NCI E-105-2012-0-JP-08 Murine Anti-NY-ESO-1 T Cell Receptors JP National Stage 514144/2015 Issued
NIAID E-275-2008-2-US-04 Preventing or Treating Viral Infection Using an Inhibitor of the LSD1 Protein, A MAO Inhibitor or an Inhibitor of LSD1 and a MAO Inhibitor US DIV 14/543,321 9499821 Issued PDF
NCI E-105-2012-0-IL-07 Murine Anti-NY-ESO-1 T Cell Receptors IL National Stage 235720 Issued
NIAMS E-762-2013-1-CA-03 ENGINEERING NEURAL STEM CELLS USING HOMOLOGOUS RECOMBINATION CA National Stage 2930590 Issued
NIAMS E-762-2013-1-PCT-01 ENGINEERING NEURAL STEM CELLS USING HOMOLOGOUS RECOMBINATION PCT PCT COMB PCT/US2014/065769 Expired
NCATS E-751-2013-0-PCT-02 Method of Blocking Transmission of Malarial Parasite PCT PCT PCT/US2014/065671 Expired
NIDDK E-034-2015-0-US-01 Device and System for Manipulating Small Model Organisms US 62/080,181 Abandoned